TP53 and Li-Fraumeni syndrome: Fourteen variants were predicted as “likely benign” and 10 as “variants of unknown significance.” The variant rs587782769 of TP53 was the only one predicted as “likely pathogenic,” because of previous associations with Li-Fraumeni syndrome, a predisposing syndrome of hereditary cancer.